ATA902490A - Rekombinantes pockenvirus-wirtsselektionssystem - Google Patents
Rekombinantes pockenvirus-wirtsselektionssystemInfo
- Publication number
- ATA902490A ATA902490A AT0902490A AT902490A ATA902490A AT A902490 A ATA902490 A AT A902490A AT 0902490 A AT0902490 A AT 0902490A AT 902490 A AT902490 A AT 902490A AT A902490 A ATA902490 A AT A902490A
- Authority
- AT
- Austria
- Prior art keywords
- selection system
- host selection
- virus host
- small virus
- recombinant small
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/320,471 US5155020A (en) | 1989-03-08 | 1989-03-08 | Recombinant poxvirus host range selection system |
US47817990A | 1990-02-14 | 1990-02-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA902490A true ATA902490A (de) | 1995-09-15 |
AT400955B AT400955B (de) | 1996-05-28 |
Family
ID=26982509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0902490A AT400955B (de) | 1989-03-08 | 1990-03-02 | Rekombinantes pockenvirus-wirtsselektionssystem |
Country Status (15)
Country | Link |
---|---|
US (1) | US5453364A (de) |
JP (1) | JP3044062B2 (de) |
AT (1) | AT400955B (de) |
AU (1) | AU625584B2 (de) |
BE (1) | BE1004212A5 (de) |
CA (1) | CA2011654C (de) |
CH (1) | CH682669A5 (de) |
DE (1) | DE4090351T1 (de) |
DK (1) | DK157091A (de) |
GB (1) | GB2245272B (de) |
IE (1) | IE62441B1 (de) |
IT (1) | IT1239987B (de) |
LU (1) | LU88000A1 (de) |
NL (1) | NL9020389A (de) |
WO (1) | WO1990010693A1 (de) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US5364773A (en) * | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
BR9106879A (pt) | 1990-09-25 | 1993-07-20 | Cantab Pharma Res | Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante |
US5665362A (en) * | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
US7374768B1 (en) | 1990-09-25 | 2008-05-20 | Xenova Research Limited | Viral vaccines |
US5837261A (en) * | 1990-09-25 | 1998-11-17 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
AU699903B2 (en) * | 1990-11-20 | 1998-12-17 | Virogenetics Corporation | Measles virus recombinant poxvirus vaccine |
US6309647B1 (en) | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
US5766598A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
KR100242671B1 (ko) * | 1991-03-07 | 2000-03-02 | 고돈 에릭 | 유전학적으로 처리한 백신 균주 |
AU672581B2 (en) * | 1991-03-07 | 1996-10-10 | Virogenetics Corporation | Immunodeficiency virus recombinant poxvirus vaccine |
DE69229390T2 (de) | 1991-08-26 | 1999-11-11 | Immuno Ag, Wien | Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus |
DK0758397T3 (da) * | 1994-04-29 | 2005-10-10 | Baxter Healthcare Sa | Rekombinante poxvira med fremmede polynucleotider i essentielle regioner |
ATE324435T1 (de) | 1995-02-21 | 2006-05-15 | Cantab Pharmaceuticals Res Ltd | Virale zubereitungen, vektoren, immunogene und impfstoffe |
EP0862449A4 (de) * | 1995-09-29 | 1998-11-11 | Immunex Corp | Chemokin-inhibitor |
AU2660397A (en) * | 1996-04-05 | 1997-10-29 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
US20030138454A1 (en) * | 1997-06-09 | 2003-07-24 | Oxxon Pharmaccines, Ltd. | Vaccination method |
US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
MXPA00008352A (es) | 1998-02-27 | 2002-10-17 | Univ Pennsylvania | Vacunas, composiciones inmunoterapeuticas y metodos para usar las mismas. |
KR20080052690A (ko) * | 1999-04-30 | 2008-06-11 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 돌연변이체 인간 cd80, 이를 포함하는 조성물, 및 이를제조하고 이용하는 방법 |
WO2001085932A2 (en) * | 2000-05-10 | 2001-11-15 | Aventis Pasteur Limited | Immunogenic polypeptides encoded by mage minigenes and uses thereof |
EP1301637B1 (de) * | 2000-07-14 | 2008-06-11 | The Trustees Of The University Of Pennsylvania | Für akzessorische hiv proteine kodierende dna impfstoffe |
CN1549730A (zh) | 2000-10-04 | 2004-11-24 | ���������Ǵ�ѧ�й��� | 黄病毒和瘟病毒衣壳蛋白的组成和使用方法 |
US8216585B2 (en) | 2001-05-25 | 2012-07-10 | The Trustees Of The University Of Pennsylvania | Targeted particles and methods of using the same |
GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
WO2003085087A2 (en) | 2002-04-09 | 2003-10-16 | Aventis Pasteur, Limited | Modified cea nucleic acid and expression vectors |
CN1596126A (zh) | 2001-11-30 | 2005-03-16 | 埃西斯创新有限公司 | 疫苗 |
WO2003072718A2 (en) * | 2002-02-22 | 2003-09-04 | Ivigene Corporation | In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
ES2256747T3 (es) * | 2002-05-16 | 2006-07-16 | Bavarian Nordic A/S | Expresion de genes en el virus de la vacuna modificado, usando el promotor ati de la viruela de la vaca. |
ATE535249T1 (de) | 2003-06-13 | 2011-12-15 | Univ Pennsylvania | Vakzine, immuntherapeutika und verfahren zu ihrer verwendung |
NZ570709A (en) | 2003-06-13 | 2010-04-30 | Univ Pennsylvania | Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
US20050175627A1 (en) * | 2003-09-24 | 2005-08-11 | Oxxon Therapeutics Ltd. | HIV pharmaccines |
JP4668919B2 (ja) * | 2003-10-08 | 2011-04-13 | サノフィ パストゥール インコーポレイテッド | 修飾cea/b7ベクター |
WO2007050095A2 (en) | 2004-11-19 | 2007-05-03 | The Trustees Of The University Of Pennsylvania | Improved vaccines and methods for using the same |
AU2007208452B2 (en) * | 2006-01-13 | 2012-07-05 | The Trustees Of The University Of Pennsylvania | Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same |
WO2007082105A2 (en) | 2006-01-16 | 2007-07-19 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chlamydia vaccine |
DK3037429T3 (en) | 2006-07-28 | 2019-01-21 | Univ Pennsylvania | IMPROVED HIV VACCINES |
US9687515B2 (en) | 2007-11-19 | 2017-06-27 | Transgene S.A. | Poxviral oncolytic vectors |
KR101542276B1 (ko) * | 2007-11-19 | 2015-08-06 | 트랜스진 에스.에이. | 폭스바이러스성 온콜리틱 벡터 |
CN102016023A (zh) * | 2008-04-04 | 2011-04-13 | 宾夕法尼亚州立大学托管会 | 使用il-28和组合物的疫苗和免疫治疗及其使用方法 |
CN101990580A (zh) * | 2008-04-04 | 2011-03-23 | 宾夕法尼亚州立大学托管会 | 屈曲病毒蛋白共有序列、编码该屈曲病毒蛋白共有序列的核酸分子和组合物及其使用方法 |
WO2010050939A1 (en) | 2008-10-29 | 2010-05-06 | The Trustees Of The University Of Pennsylvania | Improved hcv vaccines and methods for using the same |
US8921536B2 (en) | 2008-10-29 | 2014-12-30 | The Trustees Of The University Of Pennsylvania | HCV vaccines and methods for using the same |
CA2653478A1 (en) * | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
US9050287B2 (en) | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
EP2477659A4 (de) | 2009-09-14 | 2014-01-15 | Univ Pennsylvania | Impfstoffe und immuntherapeutika mit dafür kodierenden il-15-rezeptor-alpha- und/oder nukleinsäuremolekülen sowie verfahren zu ihrer anwendung |
AU2010313132B2 (en) | 2009-11-02 | 2015-01-15 | Inovio Pharmaceuticals, Inc. | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom |
US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
US9034313B2 (en) | 2010-02-08 | 2015-05-19 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
CN101935676A (zh) * | 2010-08-20 | 2011-01-05 | 中国海洋大学 | 一种诱导扇贝组织细胞体外转化的方法 |
US8927692B2 (en) | 2010-11-12 | 2015-01-06 | The Trustees Of The University Of Pennsylvania | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
KR20140007404A (ko) | 2011-01-31 | 2014-01-17 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 신규 허피스 항원을 암호화하는 핵산 분자, 이것을 포함하는 백신 및 이것의 사용 방법 |
EA202092990A3 (ru) | 2011-02-11 | 2021-07-30 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу |
US9238679B2 (en) | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
EP3662935A1 (de) | 2011-07-11 | 2020-06-10 | Inovio Pharmaceuticals, Inc. | Kreuzprotektive arenavirus-impfstoffe und deren verfahren zur verwendung |
WO2013055326A2 (en) | 2011-10-12 | 2013-04-18 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
KR101913674B1 (ko) | 2011-10-24 | 2018-10-31 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 hcv 백신 및 이것을 사용하는 방법 |
JP6407028B2 (ja) | 2011-12-12 | 2018-10-17 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用 |
EA026926B1 (ru) | 2011-12-12 | 2017-05-31 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Композиции, содержащие улучшенные генетические конструкции il-12, вакцины, иммунотерапевтические составы и способы их применения |
US10040828B2 (en) | 2012-04-10 | 2018-08-07 | The Trustees Of The University Of Pennsylvania | Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same |
EP2897628A4 (de) * | 2012-09-21 | 2016-06-22 | Agency Science Tech & Res | Neuartige abgeschwächte dengue-virusstämme zur anwendung in einem impfstoff |
KR20150130438A (ko) | 2013-03-12 | 2015-11-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 인간 파밀로마 바이러스용 개선된 백신 및 이것을 사용하는 방법 |
AU2014228405B2 (en) | 2013-03-15 | 2017-05-11 | The Trustees Of The University Of Pennsylvania | Cancer vaccines and methods of treatment using the same |
ES2817903T3 (es) | 2013-03-15 | 2021-04-08 | Univ Pennsylvania | Proteínas de consenso del virus de la Fiebre Aftosa (VFA), secuencias codificantes y vacunas preparadas a partir de las mismas |
EP3723812A4 (de) | 2017-12-13 | 2022-02-16 | Inovio Pharmaceuticals, Inc. | Gegen muc16 gerichtete krebsvakzine und verwendungen davon |
ES2938900T3 (es) | 2017-12-13 | 2023-04-17 | Inovio Pharmaceuticals Inc | Vacunas contra el cáncer dirigidas al PRAME y usos de las mismas |
JP7352547B2 (ja) | 2017-12-13 | 2023-09-28 | イノビオ ファーマシューティカルズ,インコーポレイティド | メソセリンを標的とするがんワクチンおよびその使用 |
CN112779293A (zh) * | 2021-01-27 | 2021-05-11 | 重庆市畜牧科学院 | 一种筛选LacZ基因标记山羊痘病毒的宿主细胞的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703011A (en) * | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
FR2604183B1 (fr) * | 1986-09-23 | 1988-12-30 | Transgene Sa | Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho |
CA1341245C (en) * | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
WO1989012103A1 (en) * | 1988-06-10 | 1989-12-14 | Applied Biotechnology, Inc. | Method of selecting for recombinant pox viruses |
GB2220941B (en) * | 1988-06-24 | 1991-09-11 | Nat Res Dev | Fowlpox virus non-essential regions |
US5225336A (en) * | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
BR9106879A (pt) * | 1990-09-25 | 1993-07-20 | Cantab Pharma Res | Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante |
-
1990
- 1990-03-02 JP JP2505067A patent/JP3044062B2/ja not_active Expired - Fee Related
- 1990-03-02 CH CH3600/90A patent/CH682669A5/fr not_active IP Right Cessation
- 1990-03-02 WO PCT/US1990/001268 patent/WO1990010693A1/en active Application Filing
- 1990-03-02 AU AU53320/90A patent/AU625584B2/en not_active Ceased
- 1990-03-02 DE DE4090351T patent/DE4090351T1/de not_active Withdrawn
- 1990-03-02 NL NL9020389A patent/NL9020389A/nl not_active Application Discontinuation
- 1990-03-02 AT AT0902490A patent/AT400955B/de not_active IP Right Cessation
- 1990-03-07 CA CA002011654A patent/CA2011654C/en not_active Expired - Fee Related
- 1990-03-07 IE IE81490A patent/IE62441B1/en not_active IP Right Cessation
- 1990-03-08 BE BE9000259A patent/BE1004212A5/fr not_active IP Right Cessation
- 1990-03-08 IT IT19623A patent/IT1239987B/it active IP Right Grant
-
1991
- 1991-08-20 GB GB9117996A patent/GB2245272B/en not_active Expired - Fee Related
- 1991-09-04 LU LU88000A patent/LU88000A1/fr unknown
- 1991-09-06 DK DK157091A patent/DK157091A/da not_active IP Right Cessation
-
1993
- 1993-08-05 US US08/102,702 patent/US5453364A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU5332090A (en) | 1990-10-09 |
DK157091A (da) | 1991-09-26 |
WO1990010693A1 (en) | 1990-09-20 |
IT9019623A0 (it) | 1990-03-08 |
IT1239987B (it) | 1993-11-27 |
US5453364A (en) | 1995-09-26 |
IE900814L (en) | 1990-09-08 |
DK157091D0 (da) | 1991-09-06 |
NL9020389A (nl) | 1991-12-02 |
JPH04503904A (ja) | 1992-07-16 |
AU625584B2 (en) | 1992-07-16 |
DE4090351T1 (de) | 1997-07-24 |
IT9019623A1 (it) | 1991-09-08 |
GB2245272A (en) | 1992-01-02 |
AT400955B (de) | 1996-05-28 |
CH682669A5 (fr) | 1993-10-29 |
CA2011654C (en) | 1995-12-19 |
GB2245272B (en) | 1993-03-17 |
LU88000A1 (fr) | 1992-03-11 |
CA2011654A1 (en) | 1990-09-08 |
GB9117996D0 (en) | 1991-10-09 |
IE62441B1 (en) | 1995-02-08 |
BE1004212A5 (fr) | 1992-10-13 |
JP3044062B2 (ja) | 2000-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA902490A (de) | Rekombinantes pockenvirus-wirtsselektionssystem | |
ATA902590A (de) | Rekombinantes pockenvirus | |
DK603888A (da) | Rekombinant virus | |
FR2621487B1 (fr) | Virus avipox recombinant | |
ATA257190A (de) | Virales polypeptid | |
DE69021899D1 (de) | DMA-Steuerung. | |
ZA901676B (en) | Recombinant poxvirus host range selection system | |
DE69030908D1 (de) | Akustisch-digitales System | |
ATE120489T1 (de) | Rekombinante coccidiosis-vakzine. | |
NO914402L (no) | Roer-haandteringssystem | |
FR2620459B1 (fr) | Virus recombinant de la vaccine | |
DE69030931D1 (de) | Mehrfachsequenzprozessorsystem | |
DK0517292T3 (da) | Rekombinant Avipox-virus | |
DE69031206D1 (de) | Rechnersystem | |
NO901285L (no) | Syklonsystem. | |
DE69101683D1 (de) | Rekombinantes Mareks-Krankheitsvirus. | |
DE69031904D1 (de) | Dateiensystem | |
DE69032145D1 (de) | Schnittstellensteuerungssystem | |
FI900011A0 (fi) | Kolmoisvetoakselijärjestelmä | |
DK219187A (da) | Rekombinant-virus | |
DE59005377D1 (de) | Rechnersystem. | |
ATE95566T1 (de) | Cucumber-mosaikvirus-huellproteingen. | |
DK381789D0 (da) | Peptider | |
DE3890874T1 (de) | Rekombinante avipoxviren | |
SE8901165D0 (sv) | Styrsystem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |